Eli Lilly’s retatrutide has crossed the 30% weight loss benchmark in some patients. Where do GLP-1RAs go from here?

The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...

June 2026Datroway recommended for approval in the EU by CHMP as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy Recommendation ...

This Boulder biotech advancing cancer drugs saw a notable insider sale amid strong 1-year stock gains and early clinical ...

Clinical data reveals male factors contribute to half of all infertility cases, shifting the focus toward earlier ...

The Invesco Health Care Fund underperformed its benchmark in Q1 2026 due to poor stock selection in pharmaceuticals. Read the ...

Acquisition of oncology company Sanmirna Therapeutics Inc for its clinical-stage Acute Myeloid Leukaemia RNA therapy ...

Internet-based vestibular rehabilitation (VR) is not superior to written instructions for reducing vestibular symptoms six ...

CSL Ltd (ASX: CSL) shares have lost more than half their value in a year. Is the ASX healthcare share a screaming bargain or ...

The National Testing Agency (NTA) successfully conducted the NEET UG 2026 re-examination today, June 21, from 2 PM to 5:15 PM ...

Calling all romance fans: One of #BookTok 's most popular reads of all time is getting the silver-screen treatment. Ali Hazelwood 's bestselling book The Love Hypothesis is being adapted into a ...

Korro Bio Inc. company and executive profile by Barron's. View the latest KRRO company infomation and executive bios.